Navigation Links
Karolinska Development Expands its Life Science Portfolio With BioChromix Pharma
Date:1/14/2010

a>

About BioChromix

BioChromix AB is a company in the life science arena that develops and commercializes products for early stage diagnosis and monitoring of Alzheimer's disease (AD), and identification of biomarkers associated to AD. The Company's methods are based on our novel and patented LCP molecules. The Company also develops an innovative non-invasive live imaging method for AD. http://www.biochromix.com

About BioChromix Pharma

BioChromix Pharma AB is a pharmaceutical company mission is to carry out research and development of novel treatments for neurodegenerative disorders based on its proprietary polymer technology for therapeutics. Current research and development is focused on the treatment of Alzheimer's disease but the prion diseases, Parkinson's disease and other neurodegenerative disorders might also be included in the future. http://www.biochromixpharma.com

For more information please contact:

Conny Bogentoft, CEO, Karolinska Development AB, Cell phone +46-70-668-61-43, info@karolinskadevelopment.com

Peter Asberg, CEO, BioChromix Pharma AB, Cell phone: +46-70-949-17-21,

SOURCE Karolinska Development AB (publ), and BioChromix AB
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation
2. Karolinska Development Portfolio Company Completes Successful Phase II Clinical Trial
3. Karolinska Development Closes Fully Subscribed New Share Issue
4. Karolinska Development Strengthens its Management Team With the Appointment of Dr Carl Harald Janson
5. Arena Pharmaceuticals Announces Merck Discontinues Development of Investigational Niacin Receptor Agonist Program for Atherosclerosis
6. Amgens Roger M. Perlmutter, M.D., Ph.D., Named 2009 AAAS Fellow, Recognized for Discovery, Development of Novel Medicines
7. AEterna Zentaris Announces Termination of Agreement with sanofi-aventis U.S. for the Development, Commercialization and Licensing of Cetrorelix in Benign Prostatic Hyperplasia
8. Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreichs Ataxia Preclinical Development Program
9. Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development
10. BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines
11. Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... occurs when the transplant recipient,s immune system identifies the ... was previously thought that T cells, the immune cells ... known as chemokines in order to migrate to the ... of Clinical Investigation , Fadi Lakkis and colleagues at ... chemokine stimulation of T cells is not required for ...
(Date:5/17/2013)... , May 17, 2013 ... the most innovative thought leaders of the medical ... Manufacturing East conference and expo, from June 18-20 ...      (Photo: http://photos.prnewswire.com/prnh/20130517/613829 ) , ... to deliver industry professionals practical presentations and implementable ...
(Date:5/17/2013)... Men’s skin is biologically different than women’s skin,( says skin ... known to react more aggressively when hormones change, and acne ... other acne causing factors like P.acnes bacteria and excess dirt ... unsightly acne scars. Adult acne treatment, Probiotic Action shares new ... to reduce and prevent acne scarring. , In order to ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 Tooth decay is ... showing active signs of the disease. The World Health Organization ... nearly 100% of adults have cavities. What are the long-term ... is showing a strong connection between the oral bacterial imbalance ... this disease so rampant, yet it is also 100% preventable? ...
Breaking Biology Technology:MedTech Innovate Seminars: New Interactive Learning Forums at 2013 MD&M East 2Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3
... CD9 therapeutic antibody to be presented at AACR ... Special Conference on Cancer Stem Cells -, ... biotechnology company discovering and developing the next wave of,antibody therapeutics, ... anti-CD9 cancer stem cell antibody will be,presented at the AACR ...
... has chosen the Austrian chemist Thomas Lummerstorfer (31) as ... Lummerstorfers paper Monolayers at solid-solid interfaces probed with infrared ... gain substantial importance in various fields of nanoscience. ... ABC cover. The Award is accompanied by EUR ...
... Inc. (Nasdaq: NSTK ) announced today that ... further reduce operating expenses and,align the company,s workforce ... "The workforce reduction of approximately 50 employees will ... RNAi programs forward in a more,efficient manner for ...
Cached Biology Technology:ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells 2ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells 3ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells 4Nastech Pharmaceutical Company Implements Additional Workforce Reduction as Part of Previously Announced Corporate Restructuring 2
(Date:5/16/2013)... to predict the stability of today,s largest ice sheets in ... million years ago, for example when Earth was going ... of a high sea level due to ice sheet collapse ... think that if the world,s largest ice sheets collapsed in ... our modern, progressively warming world. , However, a new ...
(Date:5/16/2013)... The endothelium, the cellular layer lining the ... a few hundred nanometers in thickness, this super-tenuous ... and tissue compression to create a unique and ... to partition tissues from the body,s circulatory system. ... the barrier must be physically breached to ...
(Date:5/16/2013)... S.C. , May 16, 2013 ... in combination with a custom thin film transistor ... highest forensic quality roll image in the smallest ... today. Sherlock, an Appendix F Mobile ID FAP ... a 95% reduction in size and weight when ...
Breaking Biology News(10 mins):World's biggest ice sheets likely more stable than previously believed 2Endothelium, heal thyself 2Endothelium, heal thyself 3Endothelium, heal thyself 4
... dose of X chromosomes by coating one of them with a ... chromosome from which it is transcribed and initiates a series of ... 2009 issue of the Journal of Cell Biology ( ... dissociates from the X chromosome during mitosis and find that Aurora ...
... Costa, principal investigator of the Champalimaud Neuroscience Programme at ... one of only 219 recipients of the prestigious European ... the 2009 edition of this flagship award scheme. The ... period of five years, will allow Rui Costa,s young ...
... CLEVELAND August 23, 2009 Case Western Reserve ... for RNA Molecular Biology, Jeff Coller, Ph.D., and his ... ribosomes, fundamentally altering a common understanding of how gene ... mRNA decay in Saccharomyces cerevisiae ", is published ...
Cached Biology News:Aurora B answers an XIST-ential question 2IGC scientist awarded prestigious European Research Council Starting grant 2Case Western Reserve University researcher demonstrates that messenger RNA are lost in translation 2
... CyScribe Post-Labeling Kit with CyScribe GFX ... generation and purification of Cy3- and ... for complete cDNA labeling and purification.Flexible ... for performing labeling reactions with either ...
... ISO 9001:2000 Certified USDA Research Registered OLAW ... Training AALAS Certified Technicians ... GLP Documentation Upon Request Focus ... for all your custom immunology service needs. ...
NORMAL DONOR DONKEY SERUM...
UV-NIR light source for USB2000, HR4000, HR2000+...
Biology Products: